GGrantIndex
← Search

EARLY PHASE CLINICAL TRIAL TO EVALUATE ANTIVIRALS (APP)

$6,142,134N01FY2022AINIH

Leidos Biomedical Research, Inc., Frederick MD

Investigators

Abstract

To support a Phase I clinical trial to evaluate a promising new antiviral. The drug is intended to be used in an outpatient setting, a key objective of the Antiviral Program for Pandemics funded by the American Rescue Plan.

View original record on NIH RePORTER →